Biopharmaceutical Company Urges CMS to Preserve Payment Incentives for Infectious Disease Products
2026-06-14
PubComNonGov2026-06-14
Carter Struck
WASHINGTON, June 14 -- PolyPid Ltd., a biopharmaceutical company headquartered in Petach Tikva, Israel, has expressed strong opposition to the Centers for Medicare & Medicaid Services' (CMS) proposed . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, June 14 -- PolyPid Ltd., a biopharmaceutical company headquartered in Petach Tikva, Israel, has expressed strong opposition to the Centers for Medicare & Medicaid Services' (CMS) proposed . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026